Avandia :: Endocrinologists respond to Avandia report
Statement from the American Association of Clinical Endocrinologists regarding The New England Journal of Medicine article, ?Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes.?